PCOS Renamed to PMOS: Shift to Metabolic Syndrome Focus
Key Questions
Why is PCOS being renamed to PMOS?
The proposed change to Polycystic Ovary/Metabolic Syndrome (PMOS) highlights insulin resistance as a central driver. This reframes the condition as a metabolic disorder instead of focusing only on ovarian cysts.
How will the PMOS name change affect screening and treatment?
It supports broader screening for diabetes and cardiovascular risk. The shift also aligns management more closely with diet-based approaches.
Who is contributing to PMOS diet guidance?
Melinda E. Cater, MS, RD, LDN is featured as an expert in the PMOS Diet materials from Johns Hopkins Medicine. Additional context comes from articles such as those by Dr. Thais Aliabadi on the metabolic focus of the name change.
The proposed renaming of Polycystic Ovary Syndrome to Polycystic Ovary/Metabolic Syndrome (PMOS) highlights insulin resistance as a central driver. This reframes the condition as a metabolic disorder, opening broader screening for diabetes and cardiovascular risk, and aligning with diet-based management.